Universe Pharmaceuticals INC (NASDAQ: UPC)

Universe Pharmaceuticals INC is an offshore holding company incorporated in the Cayman Islands. Through its PRC operating entities the company manufactures markets sells and distributes traditional Chinese medicine products targeting the elderly population in China. The core activities include production of thirteen approved TCMD formulas and distribution of third party pharmaceutical medical devices and dietary supplements.

The company generates revenue primarily from the sale of its own TCMD products which are divided into chronic condition treatments and cold and flu medicines. Additionally it earns income by distributing and selling biomedical drugs medical instruments TCMPs and dietary supplements manufactured by third party producers. Customers include pharmaceutical distributors hospitals clinics and drugstore chains across multiple Chinese provinces.

Universe Pharmaceuticals INC holds a recognized position as a manufacturer of TCMD products in China's growing health and wellness market. The company benefits from strong brand names such as Bai Nian Dan and Hu Zhuo Ren rigorous quality control standards and an experienced management team. Key competitors include Taiyuan Daningtang Pharmaceuticals Co Ltd Shenyang Dongxin Pharmaceutical Industry Co Ltd China Beijing Tong Ren Tang Group Co Ltd Jiangxi Zhongyuan Pharmaceutical Co Ltd Guangzhou Pharmaceutical Co Ltd Sichuan Tiancheng Pharmaceuticals Co Ltd Jiangzhong Pharmaceuticals Co Ltd China Resources Sanjiu Medical & Pharmaceuticals Co Ltd and Jiangxi Tengwangge Pharmaceuticals Co Ltd among others.

The company serves pharmaceutical distributors hospitals clinics and drugstore chains located in provinces such as Jiangxi Jiangsu Guangdong Hubei Fujian Guangxi Shandong and other regions across China. As of the latest reporting date the total number of customers was approximately 1 906 with no single customer accounting for more than ten percent of total revenue.